AVCR Stock Overview
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Avricore Health Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.15 |
52 Week High | CA$0.30 |
52 Week Low | CA$0.10 |
Beta | -2.08 |
1 Month Change | 15.38% |
3 Month Change | -11.76% |
1 Year Change | -49.15% |
3 Year Change | -30.23% |
5 Year Change | 150.00% |
Change since IPO | -99.01% |
Recent News & Updates
Recent updates
Shareholder Returns
AVCR | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | 0% | 2.6% | -1.9% |
1Y | -49.2% | 23.3% | 3.7% |
Return vs Industry: AVCR underperformed the Canadian Healthcare Services industry which returned 25.5% over the past year.
Return vs Market: AVCR underperformed the Canadian Market which returned 3.6% over the past year.
Price Volatility
AVCR volatility | |
---|---|
AVCR Average Weekly Movement | 16.0% |
Healthcare Services Industry Average Movement | 14.6% |
Market Average Movement | 9.1% |
10% most volatile stocks in CA Market | 18.3% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: AVCR has not had significant price volatility in the past 3 months.
Volatility Over Time: AVCR's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott.
Avricore Health Inc. Fundamentals Summary
AVCR fundamental statistics | |
---|---|
Market cap | CA$14.98m |
Earnings (TTM) | -CA$1.01m |
Revenue (TTM) | CA$3.11m |
4.8x
P/S Ratio-14.9x
P/E RatioIs AVCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVCR income statement (TTM) | |
---|---|
Revenue | CA$3.11m |
Cost of Revenue | CA$2.24m |
Gross Profit | CA$870.78k |
Other Expenses | CA$1.88m |
Earnings | -CA$1.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.01 |
Gross Margin | 28.02% |
Net Profit Margin | -32.36% |
Debt/Equity Ratio | 2.2% |
How did AVCR perform over the long term?
See historical performance and comparison